Oncology Pharma Inc. (ONPH)
ONPH Stock Price Chart
Explore Oncology Pharma Inc. interactive price chart. Choose custom timeframes to analyze ONPH price movements and trends.
ONPH Company Profile
Discover essential business fundamentals and corporate details for Oncology Pharma Inc. (ONPH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
31 Oct 1994
Employees
—
Website
https://www.oncology-pharma.comCEO
George Malesek
Description
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
ONPH Financial Timeline
Browse a chronological timeline of Oncology Pharma Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2022
EPS came in at -$0.01 .
Earnings released on 30 Sept 2022
EPS came in at -$0.15 .
Stock split effective on 9 Oct 2020
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
ONPH Stock Performance
Access detailed ONPH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.